SCHEMBL14197488

SCHEMBL14197488

CCOC(=O)C(C)(C)Oc1ccc2c(c1)CCN(C(=O)c1sc(-c3ccccc3)nc1C)C2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.47
MAPT P10636 5/20 0.42
ALDH1A1 P00352 5/20 0.42
HPGD P15428 2/20 0.42
LMNA P02545 2/20 0.42
TSHR P16473 2/20 0.42
POLB P06746 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
THRA P10827 1/20 0.41
THRB P10828 1/20 0.41
PPARA Q07869 7/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
NPC1 O15118 2/20 0.39
CDC7 O00311 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.39
DBF4 Q9UBU7 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14197485 0.97 CNR1 (0.47) CNR1MAPTALDH1A1HPGDLMNA
SCHEMBL14197489 0.91 CNR1 (0.51) CNR1MAPTALDH1A1HPGDLMNA
SCHEMBL4877685 0.91 PPARA (0.47) MAPTALDH1A1THRATHRBPPARA
SCHEMBL14197497 0.87 PPARA (0.47) MAPTALDH1A1POLBL3MBTL1THRA
SCHEMBL4875329 0.87 CNR1 (0.51) CNR1MAPTALDH1A1HPGDLMNA
SCHEMBL4878373 0.85 PPARA (0.54) CNR1MAPTPOLBL3MBTL1PPARA
SCHEMBL4867536 0.82 PPARA (0.58) ALDH1A1THRATHRBPPARANPC1
SCHEMBL4878572 0.82 PPARA (0.58) CNR1MAPTALDH1A1HPGDTHRA
SCHEMBL4874167 0.81 PPARA (0.54) CNR1MAPTALDH1A1LMNAPOLB
SCHEMBL4874131 0.80 PPARA (0.55) CNR1MAPTALDH1A1POLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096916-A1 Drugs And Prodrugs Useful The Treatment Of Energy Balance In Ruminants PFIZER INC. (US) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096916-A1 Drugs And Prodrugs Useful The Treatment Of Energy Balance In Ruminants ALPP, PIGS, GYS2 CNR1 3749/4885MAPT 933/4885ALDH1A1 2168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.